INTRODUCTION: There is limited literature on opioid dependence patients for the prevalence of sexual dysfunction as assessed by validated questionnaires. AIM: To study the prevalence and specified demographic and clinical correlates of sexual dysfunction in men seeking treatment for opioid dependence by using multiple validated instruments. METHODS: Men with opioid dependence for at least 1 year as per DSM-IV (confirmed by Mini International Neuropsychiatric Interview) (OD group, N=100) and matched healthy controls (HC group, N=50) were evaluated for sexual dysfunction. MAIN OUTCOME MEASURES: Arizona Sexual Experience Questionnaire (ASEX), International Index of Erectile Function (IIEF) and Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14). RESULTS: In men seeking treatment for opioid dependence sexual dysfunction was recorded in 48% by ASEX, and in at least one of the domains in 92% by IIEF and in 90% by CSFQ; in comparison with the healthy controls, the prevalence of sexual dysfunction in patients with opioid dependence was significantly higher by each measure. CONCLUSIONS: Compared with healthy controls, sexual dysfunction rates are higher in patients seeking treatment for opioid dependence.
INTRODUCTION: There is limited literature on opioid dependencepatients for the prevalence of sexual dysfunction as assessed by validated questionnaires. AIM: To study the prevalence and specified demographic and clinical correlates of sexual dysfunction in men seeking treatment for opioid dependence by using multiple validated instruments. METHODS:Men with opioid dependence for at least 1 year as per DSM-IV (confirmed by Mini International Neuropsychiatric Interview) (OD group, N=100) and matched healthy controls (HC group, N=50) were evaluated for sexual dysfunction. MAIN OUTCOME MEASURES: Arizona Sexual Experience Questionnaire (ASEX), International Index of Erectile Function (IIEF) and Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14). RESULTS: In men seeking treatment for opioid dependence sexual dysfunction was recorded in 48% by ASEX, and in at least one of the domains in 92% by IIEF and in 90% by CSFQ; in comparison with the healthy controls, the prevalence of sexual dysfunction in patients with opioid dependence was significantly higher by each measure. CONCLUSIONS: Compared with healthy controls, sexual dysfunction rates are higher in patients seeking treatment for opioid dependence.